Shares of IQVIA (IQV) surged past a buy point Tuesday after the provider of clinical research services beat second-quarter estimates and raised guidance. Revenue climbed 8.7% to $4.368 billion year over year, while adjusted earnings increased 12% to $3.15 a share. Analysts, on average, expected revenue of $4.310 billion. The consensus earnings estimate was $3.03 per share.
Bankomat
IQVIA Shares Surge After Beating Second Quarter Estimates
News | 2026/07/28 16:04
IQVIA Raises Its Revenue Guidance
Share
Read also
NewsArmenia, Vietnam seek deeper bilateral cooperation
September 1, 202621:02
NewsErdogan pledges continued support for Armenia-Azerbaijan peace
September 1, 202621:02
NewsANC, Armenia-Iran Strategic Center sign cooperation memo
September 1, 202621:02
NewsArmenia renames Foreign Ministry to include international trade
September 1, 202621:01